首页 › 基金 › RTW INVESTMENTS, LP › URGN
RTW INVESTMENTS, LP 对 URGN 的持仓历史
UROGEN PHARMA LTD · 医疗保健
RTW INVESTMENTS, LP 在 Q3 2026 的 13F 申报中披露持有 URGN(UROGEN PHARMA LTD)4,543,895 股,市值约 US$184.6M,约占其申报组合的 1.86%,在其申报持仓中市值排名第 18 位。 RTW INVESTMENTS, LP 最近 13 个申报季度中有 13 个季度披露了 URGN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
RTW INVESTMENTS, LP 对 URGN 的持仓演变
RTW INVESTMENTS, LP 于 Q3 2023 首次披露 URGN 持仓:857,464 股(约 US$12.0M)。 该持仓在 Q3 2026 达到峰值 4,543,895 股,市值约 US$184.6M。 在 13 次申报中,RTW INVESTMENTS, LP 6 次增持、0 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 4,543,895 股、市值约 US$184.6M。 持仓曾出现大幅变动:Q4 2023 增持约 101% (随后一个季度股价基本持平)、Q1 2024 增持约 89% (随后一个季度股价上涨 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 857.46K | $12.01M | 新进 |
| Q4 2023 | 1.73M | $25.90M | 增持 |
| Q1 2024 | 3.26M | $48.86M | 增持 |
| Q2 2024 | 3.56M | $59.69M | 增持 |
| Q3 2024 | 3.79M | $48.10M | 增持 |
| Q4 2024 | 3.83M | $40.84M | 增持 |
| Q1 2025 | 3.83M | $42.41M | 持有 |
| Q2 2025 | 4.54M | $62.25M | 增持 |
| Q3 2025 | 4.54M | $90.65M | 持有 |
| Q4 2025 | 4.54M | $106.42M | 持有 |
| Q1 2026 | 4.54M | $81.70M | 持有 |
| Q2 2026 | 4.54M | $167.22M | 持有 |
| Q3 2026 | 4.54M | $184.62M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 URGN 与 13F 数据
URGN(UROGEN PHARMA LTD)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 URGN,申报仓位最大的包括:Kynam Capital Management, LP (US$98.9M), Jefferies Financial Group Inc. (US$89.4M), ACORN CAPITAL ADVISORS, LLC (US$67.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 URGN 的基金
- Kynam Capital Management, LP 2.43M 股 · $98.90M · Q3 2026
- Jefferies Financial Group Inc. 2.20M 股 · $89.37M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 1.65M 股 · $66.98M · Q3 2026
- Opaleye Management Inc. 1.44M 股 · $52.99M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.15M 股 · $46.67M · Q3 2026
- MPM BioImpact LLC 933.41K 股 · $34.35M · Q2 2026
- Soleus Capital Management, L.P. 829.81K 股 · $30.54M · Q2 2026
- Parkman Healthcare Partners LLC 750.20K 股 · $30.48M · Q3 2026
- Boxer Capital Management, LLC 500.00K 股 · $18.40M · Q2 2026
- ADAR1 Capital Management, LLC 369.79K 股 · $15.02M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 297.08K 股 · $12.07M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 184.39K 股 · $7.49M · Q3 2026
更多关于 RTW INVESTMENTS, LP
常见问题
How long has RTW INVESTMENTS, LP held URGN?
RTW INVESTMENTS, LP has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in URGN?
As of Q3 2026, RTW INVESTMENTS, LP holds 4.54M shares of URGN (UROGEN PHARMA LTD), valued at $184.62M, representing 1.86% of its reported portfolio and ranking #18.
Has RTW INVESTMENTS, LP been buying or selling URGN?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in URGN. The position peaked in Q3 2026 at 4.54M shares.
Which other funds hold URGN?
Other major institutional holders of URGN include Kynam Capital Management, LP, Jefferies Financial Group Inc., ACORN CAPITAL ADVISORS, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.